Mills Paul C, Ghodasara Priya, Satake Nana, Alawneh John, Fraser Brandon, Kopp Steven, McGowan Michael
School of Veterinary Science, The University of Queensland, Gatton Campus, Gatton 4343, Australia.
Animals (Basel). 2020 Dec 20;10(12):2442. doi: 10.3390/ani10122442.
There is a critical need to ensure that all cattle undergoing surgical husbandry procedures are provided effective pain relief. Non-steroidal anti-inflammatory drugs (NSAIDs) are most commonly used, and typically are administered by intramuscular (IM) injection. However, administration of NSAIDs via this route to large numbers of cattle which are handled only once or twice a year, typical of many rangeland beef production systems, presents significant occupational health and safety and mis-administration risks. To address this, a novel transdermal (TD) formulation of ketoprofen was developed, and its efficacy assessed in a study of 36 Holstein-Friesian calves which were assigned to a placebo (n = 10), a TD ketoprofen (n = 10), an IM ketoprofen (n = 10) and sham dehorned group (n = 6). TD ketoprofen significantly reduced plasma cortisol concentrations between 1 to 4 h after dehorning compared to placebo treated calves, with concentrations at 2 and 4 h being very similar to those for sham dehorned calves. The expected log count of positively associated pain variables (ear flick, tail wag, ruminating, head shake, lying down, grooming and neck extending) in the TD group was reduced by 42%, compared to placebo calves, with an overall significant ( < 0.05) treatment effect. The IM group exhibited similar responses and both TD and IM cattle had a higher BW gain at 2 and 5 ( < 0.05) weeks post-dehorning, compared to placebo. This study has shown that TD administered ketoprofen was at least as effective as IM to control pain associated with dehorning and facilitates the administration of analgesic drugs prior to the surgical husbandry procedures being performed.
迫切需要确保所有接受外科饲养程序的牛都能获得有效的疼痛缓解。非甾体抗炎药(NSAIDs)是最常用的,通常通过肌肉注射(IM)给药。然而,对于许多牧场牛肉生产系统中典型的每年只处理一两次的大量牛,通过这种途径施用NSAIDs存在重大的职业健康和安全以及用药错误风险。为了解决这个问题,开发了一种新型的酮洛芬透皮(TD)制剂,并在一项对36头荷斯坦 - 弗里生犊牛的研究中评估了其疗效,这些犊牛被分配到安慰剂组(n = 10)、TD酮洛芬组(n = 10)、IM酮洛芬组(n = 10)和假去角组(n = 6)。与接受安慰剂治疗的犊牛相比,TD酮洛芬在去角后1至4小时显著降低了血浆皮质醇浓度,在2小时和4小时的浓度与假去角犊牛的浓度非常相似。与安慰剂犊牛相比,TD组中与疼痛正相关变量(耳部轻拂、尾巴摆动、反刍、摇头、躺下、梳理毛发和颈部伸展)的预期对数计数降低了42%,具有总体显著(<0.05)的治疗效果。IM组表现出类似的反应,与安慰剂相比,TD和IM组的牛在去角后2周和5周(<0.05)体重增加更高。这项研究表明,经TD给药的酮洛芬在控制与去角相关的疼痛方面至少与IM一样有效,并且便于在进行外科饲养程序之前施用镇痛药。